In the course of preparation of requirements to safety, effectiveness of medicines based on up-to-date scientifically grounded information about the clinical use of medicinal products containing as an active substance paclitaxel in the form of a drug - a concentrate for the preparation of a solution for infusions of 6 mg / ml, the need to update the instructions for the use of drugs was identified.
We inform you that the reference preparation, Taxol® in the form of a concentrate for the preparation of a solution for infusions of 6 mg / ml, from Bristol-Myers Squibb Company, USA, has been updated in the instructions for use (sections "Pharmacological properties", "Indications for use" Contraindications "," With caution "," Method of administration and dose "," Side effect "," Interaction with other medicinal products "," Special instructions ").This instruction is available on the GRLS portal.
Complete instruction of Taxol® is here.